DUSONCHET, Luisa
 Distribuzione geografica
Continente #
NA - Nord America 921
EU - Europa 558
AS - Asia 120
SA - Sud America 2
AF - Africa 1
Totale 1602
Nazione #
US - Stati Uniti d'America 921
UA - Ucraina 157
IT - Italia 116
FI - Finlandia 91
CN - Cina 86
IE - Irlanda 42
DE - Germania 41
SE - Svezia 37
GB - Regno Unito 29
RU - Federazione Russa 20
BE - Belgio 12
KR - Corea 10
IN - India 8
FR - Francia 5
TR - Turchia 5
IR - Iran 4
RO - Romania 4
BR - Brasile 2
UZ - Uzbekistan 2
AT - Austria 1
EG - Egitto 1
GR - Grecia 1
HK - Hong Kong 1
JP - Giappone 1
LB - Libano 1
LU - Lussemburgo 1
NL - Olanda 1
PK - Pakistan 1
VN - Vietnam 1
Totale 1602
Città #
Fairfield 129
Ann Arbor 121
Chandler 96
Woodbridge 86
Jacksonville 68
Wilmington 58
Ashburn 53
Houston 50
Seattle 46
Cambridge 42
Dublin 39
Palermo 24
Medford 23
Nanjing 21
Princeton 17
Tulsa 15
Altamura 13
Brussels 12
Boardman 11
Des Moines 9
Lawrence 9
San Mateo 9
Seongnam 9
Shenyang 9
Nanchang 8
Beijing 7
Dearborn 7
Milan 7
Tianjin 7
Verona 6
Auburn Hills 5
Changsha 5
Izmir 5
San Diego 5
Hebei 4
Jiaxing 4
Saint Petersburg 4
San Paolo di Civitate 4
Zhengzhou 4
Tehran 3
Jinan 2
Kunming 2
Los Angeles 2
New York 2
Ningbo 2
Apo 1
Bologna 1
Bremen 1
Central District 1
Changchun 1
Chicago 1
Durham 1
Guangzhou 1
Haikou 1
Hangzhou 1
Hanoi 1
Hanover 1
Hefei 1
Indiana 1
Islamabad 1
Lanzhou 1
Manipal 1
Orange 1
Redwood City 1
Rome 1
San Francisco 1
San Giuliano 1
Siracusa 1
Taiyuan 1
Taizhou 1
Ürümqi 1
Totale 1090
Nome #
Heterocyclic and Phenyl Double-Bond-Locked Combretastatin Analogues Possessing Potent Apoptosis-inducing activity in HL60 and in MDR Cell lines 184
Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells 172
Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3’-C-methyladenosine in leukaemia cells 130
Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives 127
Expression of the IAPs in multidrug resistant tumor cells 123
Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells 122
Chemioterapici antibatterici 121
The synergistic apoptotic effects of thiophenfurin, an inosine monophosphate dehydrogenase inhibitor, in combination with retinoids in HL60 cells. 117
Resistance to gemcitabine in a lymphoma cell line resistant to Fas-mediated apoptosis 84
Expression of IAPs (Inhibitory of Apoptosis Proteins) and of their alternative splice variants in hepatocellular carcinoma tissues and cells 71
Histone deacetylase (HDAC) inhibitors potentiate the antiproliferative and apoptotic effects induced by the novel ribonucleotide reductase (RR) inhibitor 3'-metil-adenosine (3'-Me-Ado) in promyelocitic leukemia cell lines 64
Epigenetic agents as an adjunct to active chemotherapy in hematological tumor cell lines 59
Antitumor profile of new phenothiazine derivatives. 58
Antitumor effects of novel co-drugs linking histone deacetylase and ribonucleotide reductase inhibitors in hematological tumors 52
Hydroxamic acid-containing histone deacetylase inhibitors potentiate the antiproliferative and apoptotic effects induced by the ribonucleotide reductase R1 inhibitor 3'-C-methyl-adenosine in promyelocytic leukemia cell lines 51
Histone deacetylase (HDAC) inhibition modulates intracellular deoxynucleotides (dNTP) pools and potentiates the antitumor effects of the ribonucleotide reductase (RR) inhibitor 3’-Methyl-adenosine (3’-Me-Ado) in promyelocitic leukaemia cell lines. 48
Cytotoxic and apoptotic effects of thiophenfurin in combination with retinoids in human promyelocitic leucemia HL60 cells 45
Totale 1628
Categoria #
all - tutte 2627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2627


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201854 0000 00 218 3949
2018/2019180 7821 023 193 10174248
2019/2020412 59222826 4550 4723 50162224
2020/2021265 933922 447 259 41152526
2021/2022218 1354314 68 1111 22321232
2022/2023195 3148135 3339 80 0000
Totale 1628